Navigation Links
Merck Announces Plans for Licensing Atripla Widely in Developing World

Merck & Co is seeking to register its three-in-one fixed dose combination Atripla in 66 developing countries, in addition to seeking// World Health Organization prequalification for the product, the company announced on Friday.

Atripla, which is a single tablet containing a daily dose of efavirenz, tenofovir and emtricitabine, will be priced at $613 a year for least developed countries and higher prevalence middle income countries (>1% HIV prevalence), and $1032 a year for other middle-income countries that qualify for a discounted price.

Atripla will be sold in developing countries as a white tablet in order to differentiate it from the salmon-pink tablet sold in the United States, in order to reduce the risk of diversion of product from developing countries.

Atripla is a collaboration between Merck, the license holder for efavirenz outside the US and western Europe, and Gilead, the license holder of tenofovir and emtricitabine. In contrast to Gilead's policy with tenofovir, where the company has granted voluntary licenses in India and South Africa, Atripla commercialisation will remain in the hands of the patent holders. This is likely to prevent any significant competitive pressure on the price of the product, since once licenses are granted, competition from generic versions of this fixed dose combination will be impossible without the granting of compulsory licenses for rival versions.

Although Merck will be able to import Atripla into eleven countries on the basis of US Food and Drug Administration registration, licensing in other countries may take several years in some cases owing to lack of regulatory agency capacity. Tenofovir, one of the components of Atripla, remains unlicensed in South Africa despite the grant of a voluntary license for the product to South African manufacturer Aspen in 2004. According to the Treatment Action Campaign, Aspen’s version of tenofovir was already under fast track review by South Africa’s Medicines Control Council in June 2006.

The combination of efavirenz, tenofovir and emtricitabine has been recommended by the World Health Organization as a preferred first-line combination wherever it is available, because of the reduced risk of toxicity when compared to a stavudine (d4T)-based regimen.

Source-Bio-Bio Technology
SR
'"/>




Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. Merck to pay $ 253.5 million to Vioxx victim family
3. Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
4. Judgment In Favor Of Merck For Vioxx Drug
5. Merck, ICMR to conduct joint trials on cervical cancer vaccine
6. Merck in the Dock Due To Vioxx
7. Merck Says Januvia Effective In Type 2 Diabetes
8. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
9. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
10. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
11. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... May 26, 2017 , ... The Radiology Business Management ... on current legislative activity and the latest regulatory concerns impacting RBMA members. The ... 10, and will continue through Monday, Sept. 11, at the Ritz-Carlton, Tysons Corner ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community ... healthiest seniors are located in the Midwest. With the average cost of healthcare rising ... are concerned with both the quality and affordability of where they live. An annual ...
(Date:5/26/2017)... ... ... On May 24, the Congressional Budget Office (CBO) projected that the amended American ... result in 23 million Americans losing their health insurance by 2026 as compared with ... Care Act (ACA). , “It is clear from the CBO analysis that the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Silver Birch of Hammond, a new ... on more than four acres of land at 5620 Sohl Avenue in Hammond, serves ... square-foot building includes 125 studio and one-bedroom apartments. Each of the private apartments at ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “When the ... Lead Home” is the creation of published author Laura Weigel Douglas, an avid reader ... cat in a house that sometimes feels like Green Hills Adventure Camp. She couldn’t ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... , May 18, 2017  Two Bayer U.S. Pharmaceutical ... (HBA) during its recent 28 th Woman ... The event showcases HBA,s longstanding mission of furthering the ... healthcare. Cindy Powell-Steffen , senior director ... Radiology division, and Libby Howe , a regional ...
(Date:5/12/2017)... , May 12, 2017  The China and Canada ... technology that consumes less water, energy and detergent, and features a ... product LaughingU, a shoebox-sized washing machine that washes and sanitizes women,s ... ... LaughingU, is compact, and does not require an external water inlet. ...
(Date:5/10/2017)... -- The Corporate Whistleblower Center says, "We are urging ... to call us anytime at 866-714-6466 if they possess ... a substantial scheme to overbill Medicare. We are ... of a medical equipment company if their employer ... practice groups with extra generous incentives to use, or ...
Breaking Medicine Technology: